However, several studies have proposed that andrographolide exerts anti-cancer activity through an effect on TLR4/NF-kB31, 44, 45, 46, and a recent proteomic analysis identified NF-kB as a specific andrographolide binding target47. Here, NFKB1 is linked to cancer.